Pediatric AML: Clinical Trials

3 trials for Pediatric AML, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 unknown. 3 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Not yet recruiting 1, Unknown 1
Phase 12Completed 1, Not yet recruiting 1
Phase 31Unknown 1

Follow Pediatric AML: new trials by email Literature Review of Pediatric AML trials Research Report on Pediatric AML

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia
sonrotoclax, Azacitidine, Inotuzumab ozogamicin - Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Phase 1 / Phase 2Not yet recruitingBeOne Medicines302026-12-012026-10-26
Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children
Cladribine, G-CSF, Cytarabine - Leukemia, Monocytic, Acute, Pediatric AML
Phase 2 / Phase 3UnknownSun Yat-Sen Memorial Hospital of Sun Yat-Sen University432021-12-012023-07-27
A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)
PEG- BCT-100 - Cancer, Pediatric Solid Tumor
Phase 1 / Phase 2CompletedUniversity of Birmingham492018-08-282022-09-02

Narrower conditions

Neoplasms (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Burkitt Lymphoma (1)  ·  Leukemia, Monocytic, Acute (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Recurrence (1)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Leukemia (3)  ·  Neoplasms by Histologic Type (3)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia, Lymphoid (2)  ·  Leukemia, Myeloid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  DNA Virus Infections (1)  ·  Disease Attributes (1)  ·  Epstein-Barr Virus Infections (1)  ·  Herpesviridae Infections (1)  ·  Infections (1)

Interventions

Azacitidine (1)  ·  BCT-100 (1)  ·  Cladribine (1)  ·  Cytarabine (1)  ·  Dexamethasone (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Idarubicin (1)  ·  Inotuzumab Ozogamicin (1)  ·  Mitoxantrone (1)  ·  Sorafenib (1)

Sponsors

BeOne Medicines (1)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)  ·  University of Birmingham (1)

Countries

Australia (1)  ·  China (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Francis J Mussai, DPhil (1)

Results publications

PMID 19242495, PMID 31279288, PMID 38357205